SCHEMBL3092165

SCHEMBL3092165

CS(=O)(=O)NC(c1cccc2ccccc12)S(=O)(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.44
RECQL P46063 1/20 0.42
NQO2 P16083 1/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
G6PD P11413 1/20 0.38
SLC6A4 P31645 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
ADRB3 P13945 1/20 0.35
ACP3 P15309 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3097296 0.85 RECQL (0.44) KEAP1RECQLALDH1A1CYP1A2CYP2C9
SCHEMBL3092268 0.80 ALDH1A1 (0.45) RECQLALDH1A1CYP2C9G6PDSLC6A4
SCHEMBL3088526 0.80 ALDH1A1 (0.45) RECQLALDH1A1G6PDMEN1KMT2A
SCHEMBL3086378 0.78 ALDH1A1 (0.49) RECQLALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL3092574 0.77 ALDH1A1 (0.58) RECQLALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL12462064 0.76 KEAP1 (0.50) KEAP1NQO2ALDH1A1CYP1A2CYP2C9
SCHEMBL12462066 0.76 KEAP1 (0.50) KEAP1NQO2ALDH1A1CYP1A2CYP2C9
SCHEMBL3092143 0.75 SLC6A4 (0.39) RECQLALDH1A1CYP2C9CYP2C19SLC6A4
SCHEMBL27747922 0.75 LMNA (0.47) ALDH1A1MEN1KMT2A
SCHEMBL3080743 0.75 SLC6A4 (0.41) ALDH1A1CYP2C9CYP2C19SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799797-B2 Arylsulfonyl naphthalene derivatives and uses thereof ROCHE PALO ALTO LLC (US) 2010-09-21 US disclosed
EP-2041079-A1 ARYLSULFONYL NAPHTHALENE DERIVATIVES AND USES THEREOF F. Hoffmann-Roche AG (CH) 2009-04-01 EP disclosed
WO-2007147763-A1 ARYLSULFONYL NAPHTHALENE DERIVATIVES AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2007-12-27 WO disclosed
US-20070293526-A1 Arylsulfonyl naphthalene derivatives and uses thereof ROCHE PALO ALTO LLC 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293526-A1 Arylsulfonyl naphthalene derivatives and uses thereof ARSA, AR, SULT2A1 KEAP1 845/4885RECQL 15/4885NQO2 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.